SCHEMBL5877945

SCHEMBL5877945

NC(=O)ON1C(=O)CC(O)C1=O

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.33
BLM P54132 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4326673 0.81 POLB (0.33)
SCHEMBL868201 0.81
SCHEMBL29980975 0.80 APEX1 (0.35) APEX1BLM
SCHEMBL2683914 0.78
SCHEMBL29407564 0.78
SCHEMBL4786241 0.77 APEX1 (0.31) APEX1BLM
SCHEMBL3236317 0.77 CHRM2 (0.33) BLM
SCHEMBL21333948 0.77 PRKCA (0.33)
SCHEMBL18725982 0.77
SCHEMBL6025641 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001096529-A2 ACETYL GLUCOSAMINYL INOSITOL DEACETYLASE, A MYCOTHIOL BIOSYNTHETIC ENZYME, AND METHODS OF USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) 2001-12-20 WO claimed
EP-4069868-A2 METHODS OF DETECTION AND ANALYSIS OF NUCLEIC ACID IN NEURAL-DERIVED EXOSOMES The Institute For Ethnomedicine DBA Brain Chemistry Labs (US) 2022-10-12 EP disclosed
WO-2020065047-A1 METHOD FOR THE STEREOISOMERIZATION OF CHIRAL COMPOUNDS EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) 2020-04-02 WO disclosed
US-7148069-B2 Method for analysis of compounds with amino group and analytical reagent therefor AJINOMOTO CO., INC. (JP) 2006-12-12 US disclosed
WO-2005110494-A2 METHODS AND COMPOSITIONS FOR THE INHIBITION OF THROMBUS FORMATION THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2005-11-24 WO disclosed
US-20050079624-A1 Method for analysis of compounds with amino group and analytical reagent therefor AJINOMOTO CO., INC (JP) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050079624-A1 Method for analysis of compounds with amino group and analytical reagent therefor CTH, VIP, SLC7A11 APEX1 2827/4885BLM 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.